Influence of lobeline on catecholamine release from the isolated perfused rat adrenal gland

Autonomic Neuroscience: Basic and Clinical

Volumn 110, Issue 1, 2004, Pages 27-35

  Lim, Dong Yoon ^a   Kim, Yang Soo ^a   Miwa, Soichi ^b  

^a Chosun University   (South Korea)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Adrenal gland; Catecholamine secretion; Lobeline (from Lobelia inflata); Nicotinic antagonist

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; 1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ADENOSINE TRIPHOSPHATASE; ALKALOID; AMMONIUM DERIVATIVE; CALCIUM CHANNEL; CATECHOLAMINE; CYCLOPIAZONIC ACID; LOBELINE; NICOTINE; PIPERAZINE DERIVATIVE; POTASSIUM; POTASSIUM CHANNEL; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CATECHOLAMINE RELEASE; CHROMAFFIN CELL; CONTROLLED STUDY; CYTOPLASM; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; EVOKED RESPONSE; MALE; MEMBRANE DEPOLARIZATION; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT;

EID: 0842346514     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2003.10.001     Document Type: Article

References (46)

1. 3H] methylcarbamylcholine in rat brain. Eur. J. Pharmacol. 253:1994;261-267.
2. Anton A.H., Sayre D.F. A study of the factors affecting the aluminum oxidetrihydroxy indole procedure for the analysis of catecholamines. J. Pharmacol. Exp. Ther. 138:1962;360-375.
3. Benwell M.E.M., Balfour D.J.K. The influence of lobeline on nucleus accumbens dopamine and locomotor responses to nicotine in nicotine-pretreated rats. Br. J. Pharmacol. 125:1998;1115-1119.
4. Boarder M.R., Marriott D., Adams M. Stimulus secretion coupling in cultured chromaffin cells, dependency on external sodium and on dihydropyridine-sensitive calcium channels. Biochem. Pharmacol. 36:1987;163-167.
5. Brioni J.D., O'Neill A.B., Kim D.J.B., Decker M.W. Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur. J. Pharmacol. 238:1993;1-8.
6. Cena V., Nicolas G.P., Sanchez-Garcia P., Kirpekar S.M., Garcia A.G. Pharmacological dissection of receptor-associated and voltage-sensitive ionic channels involved in catecholamine release. Neuroscience. 10:1983;1455-1462.
7. Clarke P.B.S., Kumar R. The effect of nicotine on locomotor activity in non-tolerant and tolerant rats. Br. J. Pharmacol. 78(2):1983;329-337.
8. Clarke P.B.S., Kumar R. Characterization of the locomotor stimulant action of nicotine in tolerant rats. Br. J. Pharmacol. 80(3):1983;587-594.
9. 3H]dopamine release. Br. J. Pharmacol. 117:1996;595-606.
10. Covernton P.J., Kojina H., Sivilotti L.G., Gibb A.J., Colquhoun D. Comparison of neuronal nicotinic receptors in rat sympathetic neurons with subunit pairs expressed in Xenopus oocytes. J. Physiol. 481:1994;27-34.
11. Damaj M.I., Patrick G.S., Creasey K.R., Martin B.R. Pharmacology of lobeline, a nicotinic AChR ligand. J. Pharmacol. Exp. Ther. 282:1997;410-419.
12. Decker M.W., Brioni J.D., Bannon A.W., Arneric S.P. Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. Life Sci. 56(8):1995;545-570.
13. Fudala P.J., Iwamoto E.T. Further studies on nicotine-induced conditioned place preference in the rat. Pharmacol. Biochem. Behav. 25:1986;1041-1049.
14. Fudala P.J., Teoh K.W., Iwamoto E.T. Pharmacologic characterization of nicotine-induced conditioned place preference. Pharmacol. Biochem. Behav. 22(2):1985;237-241.
15. Fung Y.K., Lau Y.S. Receptor mechanisms of nicotine-induced locomotor hyperactivity in chronic nicotine treated rats. Eur. J. Pharmacol. 152(3):1988;263-271.
16. 3H]norepinephrine from fetal rat coeruleus cells in culture. J. Neurochem. 70:1998;663-670.
17. Garcia A.G., Sala F., Reig J.A., Viniegra S., Frias J., Fonteriz R., Gandia L. Dihydropyridine Bay-K-8644 activates chromaffin cell calcium channels. Nature. 309:1984;69-71.
18. 2+ permeability. Biochem. Pharmacol. 38:1989;3995-4003.
19. Hamann S.R., Martin W.R. Hyperalgesic and analgesic actions of morphine, U50-488, naltrexone, and (-)lobeline in the rat brainstem. Pharmacol. Biochem. Behav. 47:1994;197-201.
20. 2 biochemical and functional characterization. Life Sci. 31:1982;2992-2998.
21. Jaramillo J., Volle R.L. A comparison of the ganglionic stimulating and blocking properties of some nicotinic drugs. Arch. Int. Pharmacodyn. Ther. 174:1968;88-97.
22. Lambert J.J., Durant N.N., Henderson E.G. Drug-induced modification of ionic conductance at the neuromuscular junction. Annu. Rev. Pharmacol. Toxicol. 23:1983;505-539.
23. 3H]5-HT from rat hippocampal slices. Neuropharmacology. 35:1996;1769-1777.
24. Lim D.Y., Kim C.D., Ahn K.W. Influence of TMB-8 on secretion of catecholamines from the perfused rat adrenal glands. Arch. Pharm. Res. 15(2):1992;115-125.
25. Lopez M.G., Fonteriz R., Gandia L., De la Fuente M., Villarroya M., Garcia-sancho J., Garcia A.G. The nicotinic acetylcholine receptor of the bovine chromaffin cell, a new target for dihydropyridines. Eur. J. Pharmacol., Mol. Biol. 247:1993;199-207.
26. + efflux from thalamic synaptosomes. Neuropharmacology. 39:2000;2654-2662.
27. Nooney J.M., Peters J.P., Lambert J.J. A patch clamp study of the nicotinic acetylcholine receptor of bovine adrenomedullary chromaffin cells in culture. J. Physiol. 455:1992;503-527.
28. Nunn-thompson C.L., Simon P.A. Pharmacotherapy for smoking cessation. Clin. Pharmacol. 8:1989;710-720.
29. O'Farrell N., Zigas J., Marley P.D. Effect of N- and L-type calcium channel antagonists and (t)-Bay-K-8644 on nerve-induced catecholamine secretion from bovine perfused adrenal glands. Br. J. Pharmacol. 121:1997;381-388.
30. Olin B.R., Hebel S.K., Gremp J.L., Hulbert M.K. Smoking deterrents. Olin B.R., Hebel S.K., Gremp J.L., Hulbert M.K., St. Louis J.B. Drug Facts and Comparisons. 1995;3087-3095 Lippincott, New York.
31. Owen P.J., Marriott D.B., Boarder M.R. Evidence for a dihydropyridine-sensitive and conotoxin-insensitive release of noradrenaline and uptake of calcium in adrenal chromaffin cells. Br. J. Pharmacol. 97:1989;133-138.
32. 3H]-nicotine to rat brain membranes and its inhibition by analogues of nicotine. Neuropharmacology. 27:1988;235-241.
33. Reavill C., Walther B., Stoleman I.P., Testa B. Behavioral and pharmacokinetics studies on nicotine, cytisine and lobeline. Neuropharmacology. 36:1990;619-624.
34. Santha E., Sperlagh B., Zelles T., Zsilla G., Toth P.T., Lendvai B., Baranyi M., Vizi E.S. Multiple cellular mechanisms mediate the effect of lobeline on the release of norepinephrine. J. Pharmacol. Exp. Ther. 294(1):2000;302-307.
35. 2+ channels. Nature. 303:1982;535-537.
36. 2+-ATPase of sarcoplasimc reticulum. J. Biol. Chem. 264:1989;17816-17823.
37. Sershen H., Balla A., Lajtha A., Vizi E.S. Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus. Neuroscience. 77(1):1997;121-130.
38. Shoaib M., Stolerman I.P., Kumar R.C. Nicotine-induced place preference following prior nicotine exposure in rats. Psychopharmacology. 113:1994;445-452.
39. Sloan J.W., Martin W.R., Bostwick M., Hook R., Wala E. The competitive binding characteristics of nicotinic ligands and their pharmacology. Pharmacol. Biochem. Behav. 30:1988;255-267.
40. Stolerman I.P., Garcha H.S., Mirza N.R. Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats. Psychopharmacology. 117(4):1995;430-437.
41. + currents in guinea-pig smooth muscle cells. Br. J. Pharmacol. 107:1992;134-140.
42. Tallarida R.J., Murray R.B. Manual of Pharmacologic Calculation with Computer Programs. 2nd ed. 1987;131-136 Springer, New York.
43. 3H]dopamine uptake. J. Pharmacol. Exp. Ther. 280(3):1997;1432-1444.
44. 2+ current in cultured neurones from rat sympathetic ganglia. Eur. J. Pharmacol. 363:1998;75-80.
45. Wada Y., Satoh K., Taira N. Cardiovascular profile of Bay-K-8644, a presumed calcium channel activator in the dog. Naunyn-Schmiedebergs Arch. Pharmakol. 328:1985;382-387.
46. Wakade A.R. Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland. J. Physiol. 313:1981;463-480.